Home
About
Overview
Sharing Data
ORCID
Help
History (94)
Phase I Trial of MCARH109, a G Protein-Coupled Receptor Class C Group 5 Member D (GPRC5D)-Targeted Chimeric Antigen Receptor T-Cell Therapy for Multiple Myeloma: An Updated Analysis.
Risk factors for prenatal depressive symptoms among Hispanic women.
The controversy inherent in managing frail nursing home residents during complex hurricane emergencies.
Heterologous prime-boost vaccination.
The evolution of N-glycan-dependent endoplasmic reticulum quality control factors for glycoprotein folding and degradation.
See All 94 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top